Insider · CIK 0001254044
Glenn E. Deegan
Files at ASPN (ASPEN AEROGELS INC). First filing -, latest -.
In brief
Glenn E. Deegan files SEC Form 4 as officer at ASPN (ASPEN AEROGELS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Glenn E. Deegan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ASPN ASPEN AEROGELS INC | FTax withholding Common Stock | -1,143 | $5.48 | $6,264 | 66,033 | 12 d ago |
| Mar 4, 2026 | ASPN ASPEN AEROGELS INC | AGrant or award Common Stock | +55,503 | $0.00 | $0 | 67,176 | Mar 6, 2026 |
| Mar 4, 2026 | ASPN ASPEN AEROGELS INC | AGrant or award Stock Options (Right to Buy)derivative | +75,171 | $0.00 | $0 | 75,171 | Mar 6, 2026 |
| Sep 30, 2025 | ASPN ASPEN AEROGELS INC | AGrant or award Common Stock | +11,673 | $0.00 | $0 | 11,673 | Oct 2, 2025 |
| Sep 30, 2025 | ASPN ASPEN AEROGELS INC | AGrant or award Stock Options (Right to Buy)derivative | +16,416 | $0.00 | $0 | 16,416 | Oct 2, 2025 |
| Sep 30, 2025 | ASPN ASPEN AEROGELS INC | AGrant or award Performance Share Unitsderivative | +23,347 | $0.00 | $0 | 23,347 | Oct 2, 2025 |
Questions about Glenn E. Deegan
Answered from the filings on this page, as of the latest one.
Is Glenn E. Deegan buying or selling?
Glenn E. Deegan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Glenn E. Deegan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Glenn E. Deegan has 0.
Where does Glenn E. Deegan file Form 4?
Glenn E. Deegan has filed Form 4 at ASPN (ASPEN AEROGELS INC) as CAO, GC & Corp Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.